Pediatric psoriasis treated with apremilast

Yu.F. Koval, L.I. Evlanova · JAAD Case Reports · 2016

Summary

This case report discusses encouraging outcomes obtained with apremilast in an adolescent patient, and standardized guidelines for treating childhood psoriasis are lacking, and there are only limited evidence-based data and approved treatments.

Type: article
Published: 2016-01-01
Cited by: 21
References: 7
DOI: https://doi.org/10.1016/j.jdcr.2015.12.005
PubMed: https://pubmed.ncbi.nlm.nih.gov/27051839/
PMC: https://www.ncbi.nlm.nih.gov/pmc/articles/4809471/
OpenAlex: https://openalex.org/W27051839
Semantic Scholar: https://api.semanticscholar.org/CorpusID:5482872

Keywords

Excretion, Organism, Chemistry, Medicine, Biology

References

Management of psoriasis in adolescenceGiovanni Baule — 2014
Prevalence of Psoriasis Among Adults in the U.SCharles G. Helmick, Hyewon Lee-Han, Shawn Hirsch — 2014
Global epidemiology of psoriasis: a systematic review of incidence and prevalence.Rosa Parisi, Deborah Symmons, C.E.M. Griffiths — 2013
INCIDENCE OF PSORIASIS IN CHILDREN: A POPULATION-BASED STUDYMegha M. Tollefson, Cynthia S. Crowson, Marian T. McEvoy — 2009
Apremilast mechanism of action and application to psoriasis and psoriatic arthritis.Peter Schäfer — 2012
A comparative study of impairment of quality of life in children with skin disease and children with other chronic childhood diseasesPaula Beattie, M.S. Lewis‐Jones — 2006
Pediatric PsoriasisMaria Relvas, Tiago Torres — 2017

Cited by

Pharmacodynamic assessment of apremilast for the treatment of moderate-to-severe plaque psoriasisLuca Bianchi, Ester Del Duca, Marco Romanelli — 2016
Apremilast for the management of moderate to severe plaque psoriasisRamya Vangipuram, Ali Alikhan — 2017
Targeted therapies for pediatric psoriasis.Gene Schwartz, Amy S. Paller — 2018
Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory DiseasesHeng Li, Jianping Zuo, Wei Tang — 2018
Pediatric dermatology—Critical approach to the new treatmentsYuan Liang, Yun Liu Chen, Mu Tong Zhao — 2018
Dramatic response of cutaneous, nail, and joint symptoms of psoriasis to apremilastManjunath Shenoy, Meghana Bathina, AminaAsfiya Iqbal — 2019
Apremilast in Psoriasis and Beyond: Big Hopes on a Small MoleculeSunil Dogra, T. P. Afra, TMuhammed Razmi — 2019
Colocalization of psoriasis and vitiligo treated with apremilast and narrowband ultraviolet B combination in an adolescent girlTrashita Hassanandani, Maitreyee Panda, Nibedita Patro — 2020
Risk assessment of therapeutic agents under consideration to treat COVID‐19 in paediatric patients and pregnant womenJeffrey S. Barrett — 2020
On- and Off-Label Uses of Apremilast in Dermatology.Kerasia‐Maria Plachouri, Sophia Georgiou — 2020
The Use of Apremilast in Psoriasis: An Indian Perspective on Real-World ScenariosMurlidhar Rajagopalan, Sunil Dogra, Abir Saraswat — 2021
Pediatric PsoriasisMaria Relvas, Tiago Torres — 2017
Apremilast in Paediatric Dermatoses – A Comprehensive ReviewNibedita Patro, Maitreyee Panda, Mrityunjay Dash — 2022
Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part I: focus on pediatric patientsMatteo Megna, Elisa Camela, Teresa Battista — 2023
Pediatric psoriasis: Biologics and oral small molecule inhibitors in modern therapyAlexandra Firek, Leslie Castelo-Soccio — 2024
Apremilast in moderate to severe plaque psoriasis: a profile of its use in paediatric patientsMichael B. Brown, Matt Shirley — 2025
Pediatric PsoriasisStarling Tolliver, A. Pepper, Salma Pothiawala — 2020
Oral Agents for PsoriasisKristen M Beck, Eric J. Yang, Ladi Afifian — 2018
PTT_A_320810 109..122M. Rajagopalan, S. Dogra, A. Saraswat — 2021
Phosphodiesterase (PDE) Inhibitors for the Treatment of Inflammatory Skin ConditionsJ. Huber, G. Krueger, Jason E. Hawkes — 2018

Pediatric psoriasis treated with apremilast

Summary

Keywords

References

Cited by

Related papers